Edition:
United Kingdom

Laurus Labs Ltd (LAUL.NS)

LAUL.NS on National Stock Exchange of India

330.05INR
10:59am BST
Change (% chg)

Rs-9.05 (-2.67%)
Prev Close
Rs339.10
Open
Rs339.10
Day's High
Rs339.95
Day's Low
Rs327.00
Volume
32,246
Avg. Vol
112,887
52-wk High
Rs503.10
52-wk Low
Rs321.35

Latest Key Developments (Source: Significant Developments)

Laurus Labs Completes U.S.FDA Inspection At Its API Facilities In Units 1 & 3
Friday, 14 Jun 2019 

June 14 (Reuters) - Laurus Labs Ltd ::COMPLETED US FOOD AND DRUG ADMINISTRATION (USFDA) INSPECTION OF ITS API FACILITIES IN UNITS 1 & 3.INSPECTION COMPLETED WITH TWO OBSERVATIONS WHICH ARE PROCEDURAL IN NATURE.  Full Article

India's Laurus Labs March-Qtr Profit Falls
Thursday, 2 May 2019 

May 2 (Reuters) - Laurus Labs Ltd ::MARCH QUARTER NET PAT 431.8 MILLION RUPEES VERSUS PROFIT 450.8 MILLION RUPEES YEAR AGO.MARCH QUARTER REVENUE FROM OPERATIONS 6.35 BILLION RUPEES VERSUS 5.60 BILLION RUPEES YEAR AGO.RECOMMENDED DIVIDEND OF 1.50 RUPEES PER SHARE.  Full Article

Laurus Labs Says USFDA Issues One Observation For Unit 6 At Vishakapatnam
Friday, 2 Nov 2018 

Nov 2 (Reuters) - Laurus Labs Ltd ::LAURUS LABS - COMPLETED USFDA INSPECTION OF UNIT 6 API INTERMEDIATE FACILITY WITH ONE OBSERVATION WHICH IS RELATED TO A PROCEDURE, ON NOVEMBER 02.LAURUS LABS - MANUFACTURING FACILITY UNIT 6 IS LOCATED AT ATCHUTAPURAM IN VISAKHAPATNAM, ANDHRA PRADESH.  Full Article

India's Laurus Labs Sept-Qtr PAT Falls
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - Laurus Labs Ltd ::SEPT QUARTER CONSOL NET PAT 162.1 MILLION RUPEES VERSUS PROFIT 487.6 MILLION RUPEES YEAR AGO.SEPT QUARTER CONSOL REVENUE FROM OPERATIONS 5.88 BILLION RUPEES VERSUS 5.39 BILLION RUPEES YEAR AGO.  Full Article

Laurus Labs Says US FDA completed Unit 2 audit without observations
Thursday, 1 Mar 2018 

March 1 (Reuters) - Laurus Labs Ltd ::Says US FDA completed audit without observations at formulations Unit 2 from Feb 26 to March 1, 2018.  Full Article

Laurus labs gets EIR from US FDA for Visakhapatnam units
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Laurus Labs Ltd :Gets EIR from US FDA for unit 1, 3, at Parawada, Visakhapatnam, for inspection conducted in August 2017​.  Full Article

India's Laurus Labs Sept-qtr consol profit rises
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Laurus Labs Ltd ::Sept quarter consol net profit 487.6 million rupees versus 482.8 million rupees year ago.Sept quarter consol revenue from operations 5.39 billion rupees versus 5.25 billion rupees year ago.  Full Article

Laurus Labs gets EIR from U.S. FDA for plant at unit 2 in Atchutapuram
Friday, 15 Sep 2017 

Sept 15 (Reuters) - Laurus Labs Ltd :Gets EIR from U.S. FDA for its finished dosage formulations & active pharmaceutical ingredients plant, unit 2, located at Atchutapuram.Unit 2 (FDF) completed BGV Hamburg inspection, units 1 & 3 completed WHO inspection this month with no critical/major observations.  Full Article

India's Laurus Labs June-qtr consol profit rises
Thursday, 10 Aug 2017 

Aug 10 (Reuters) - India's Laurus Labs Ltd :June quarter consol net profit 389.1 million rupees versus 256.4 million rupees year ago.June quarter consol total income 4.99 billion rupees versus 4.19 billion rupees year ago.  Full Article